NASDAQ: REPH       Recro Pharma Inc
Last Price Today's Change   Day's Range   Trading Volume
1.76   -0.09 (4.86%)  1.76 - 1.82  207,067


Avg Volume (4 weeks):209,435
4 Weeks Range:1.76 - 2.38
4 Weeks Price Volatility (%):
52 Weeks Range:1.76 - 19.21
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Recro Pharma Inc is a specialty pharmaceutical company focused on products for hospitals and ambulatory care settings that develops non-opioid products for the treatment of acute pain. The company operates two divisions Acute Care division and a contract development and manufacturing or CDMO division. The Acute Care division is engaged in developing products for hospital and related settings. Its lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. The CDMO division develops and manufactures pharmaceutical products using the company's proprietary delivery technologies for commercial partners who commercialize or plan to commercialize these products. The majority of the company's revenue is generated from its CDMO segment.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1579  4444  223  3154 

Top 10 Active Counters
 MGEN 1.26+0.74 
 TTNP 0.167+0.038 
 GE 7.42+0.32 
 LK 1.38+1.38 
 AAPL 111.20-5.40 
 SQQQ 24.65+2.59 
 NIO 27.51-0.93 
 NAKD 0.083-0.009 
 SNAP 42.86+1.32 
 BAC 23.47-0.38